Approval · Notice of Compliance 4303 · 1996
CEDAX: Notice of Compliance 4303
Issued November 20, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4303
- Date
- November 20, 1996
- Company
- Schering Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: provides for use in adults with acute exacerbation of chronic bronchitis (aecb)
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEDAX | Not yet assigned | — |
Medicinal ingredients
- CEFTIBUTEN 90 MG per 5ML
- CEFTIBUTEN 200 MG per CAP
- CEFTIBUTEN 400 MG per CAP
- CEFTIBUTEN 180 MG per 5ML